Rubicon Genomics and Abbott Molecular Sign Agreement to Co-Develop Simple Non-Invasive Cancer Diagnostic Tests

News   Nov 01, 2005

 
Rubicon Genomics and Abbott Molecular Sign Agreement to Co-Develop Simple Non-Invasive Cancer Diagnostic Tests
 
 
 

RELATED ARTICLES

Over 130 Glaucoma Gene Variants Could Help Predict Blindness

News

An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.

READ MORE

Yeast Study Performs Hundreds of Simultaneous CRISPR Edits

News

A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.

READ MORE

Cell Types Underlying Schizophrenia Identified

News

Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE